Customceutical Compounding recalls TriMix MEDIUM (Papaverine HCL 21 mg/mL Phentolamine Mesylate 0.7 mg/mL Alprostadil 7 mcg/mL), 2 mL multidose MDV Inj. Co
Recalled May 8, 2019 · FDA recall D-1262-2019 · Customceutical Compounding
Hazard
Lack of assurance of sterility for injectables and solutions intended to be sterile. · FDA Class II
Units
N/A
Sold at
U.S.A. Nationwide
Description
Lack of assurance of sterility for injectables and solutions intended to be sterile.
Product
TriMix MEDIUM (Papaverine HCL 21 mg/mL Phentolamine Mesylate 0.7 mg/mL Alprostadil 7 mcg/mL), 2 mL multidose MDV Inj. Compounded. Customceutical Compounding 4611 E. Shea Blvd. Bldg 3 180, Phoenix, AZ 85028 Ph. 480 516 0272
Manufacturer(s)
Customceutical Compounding
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →